CRNX: Crinetics Pharmaceuticals Inc Company Profile & Statistics

About

Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States.

Info & Links

CEO

R. Scott Struthers

Headquarters

6055 Lusk Boulevard
San Diego, CA 92121, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

Employees

290

Crinetics Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

5.08B

Enterprise Value

4.76B

Enterprise Value/EBITDA(ttm)

-14.94

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.05K

Price to Book(mrq)

5.16

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

-7254.49%

Return on Equity(ttm)

-36.12%

Return on Invested Capital(ttm)

-36.93%

Return on Assets(ttm)

-31.89%

Income Statement

Revenue(ttm)

1.04M

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

1.04M

EBITDA(ttm)³

-318.86M

Net Income Available to Common(ttm)

-277.91M

Diluted EPS(ttm)

-3.73

Share Statistics

Beta (5Y Monthly)

0.60

52-Week Change

64.04%

S&P 500 52-Week Change

27.94%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

92.74M

Dividend Yield

0.00%

Float⁴

87.17M

% Held by Insiders

6.00%

% Held by Institutions

98.51%

Balance Sheet

Total Cash(mrq)

862.67M

Total Cash Per Share(mrq)

9.30

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.38%

Quick Ratio(mrq)

16.38%

Book Value Per Share(mrq)

10.30

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.01

Free Cash Flow(ytd)

-164.11M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CRNX

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc Profile